Canaan Partners is an early-stage venture capital firm founded in 1987 as a management buyout spin-out from General Electric's venture unit. The firm invests in "visionaries with transformative ideas," backing companies from seed through Series A across a roughly 60/40 split between technology and healthcare. On the technology side Canaan funds developer tools, security, infrastructure, fintech, consumer, AI, and frontier/deep-tech companies; on the healthcare side it specializes in de novo biotech creation, therapeutics, and medical devices. Headquartered in Stamford, Connecticut with offices in San Francisco, Menlo Park, and New York City, Canaan has raised roughly $7 billion across 13 funds and is actively deploying Fund XIII. Over its 37-year history the firm reports a track record of 73 IPOs and 152 M&A exits, with notable investments including Instacart, LendingClub, The RealReal, DexCom, Match.com, Snyk, Turo, Cardlytics, and Day One Biopharmaceuticals.
aid: canaan-partners
name: Canaan Partners
description: >-
Canaan Partners is an early-stage venture capital firm founded in 1987 as a
management buyout spin-out from General Electric's venture unit. The firm
invests in "visionaries with transformative ideas," backing companies from
seed through Series A across a roughly 60/40 split between technology and
healthcare. On the technology side Canaan funds developer tools, security,
infrastructure, fintech, consumer, AI, and frontier/deep-tech companies; on
the healthcare side it specializes in de novo biotech creation, therapeutics,
and medical devices. Headquartered in Stamford, Connecticut with offices in
San Francisco, Menlo Park, and New York City, Canaan has raised roughly $7
billion across 13 funds and is actively deploying Fund XIII. Over its 37-year
history the firm reports a track record of 73 IPOs and 152 M&A exits, with
notable investments including Instacart, LendingClub, The RealReal, DexCom,
Match.com, Snyk, Turo, Cardlytics, and Day One Biopharmaceuticals.
x-type: venture-capital
x-category: Venture Capital
image: https://www.canaan.com/favicon.ico
tags:
- Venture Capital
- Seed
- Series A
- Early Stage
- Healthcare
- Biotech
- Developer Tools
- Fintech
- Consumer
- Artificial Intelligence
- North America
created: '2026-07-17'
modified: '2026-07-17'
specificationVersion: '0.20'
apis: []
common:
- type: Website
url: https://www.canaan.com
- type: Portfolio
url: https://www.canaan.com/companies
- type: Portfolio
url: portfolio/canaan-partners-portfolio.yml
- type: Team
url: https://www.canaan.com/team
- type: About
url: https://www.canaan.com/about
- type: InvestmentThesis
url: https://www.canaan.com/about
- type: Blog
url: https://www.canaan.com/latest
- type: News
url: https://www.canaan.com/latest
- type: Podcast
url: https://www.canaan.com/woven/podcasts
- type: Jobs
url: https://platform.canaan.com/careers
- type: Contact
url: https://www.canaan.com/contact
- type: LinkedIn
url: https://www.linkedin.com/company/canaan-partners
- type: Twitter
url: https://twitter.com/canaanpartners
- type: Crunchbase
url: https://www.crunchbase.com/organization/canaan-partners
- type: Features
data:
- 'Stage: Seed, Series A (early stage)'
- 'Sectors: technology and healthcare (~60/40 split) — developer tools, security, infrastructure, fintech, consumer, AI, deep tech; therapeutics, biotech, medical devices'
- 'Geography: United States (Stamford CT HQ; San Francisco, Menlo Park, New York offices)'
- 'AUM: ~$7B raised across 13 funds (self-reported)'
- 'Current fund: Fund XIII'
- 'Founded: 1987'
- 'HQ: Stamford, Connecticut'
- 'Track record: 73 IPOs, 152 M&A exits (self-reported)'
sources:
- https://www.canaan.com/about
- https://en.wikipedia.org/wiki/Canaan_Partners
updated: '2026-07-17'
maintainers:
- FN: Kin Lane
url: https://apievangelist.com
email: info@apievangelist.com
- FN: APIs.json
url: http://apisjson.org
email: info@apisjson.org
- FN: Canaan Partners
url: https://www.canaan.com
email: info@canaan.com